Identification of distinct and age‐dependent p16 High microglia subtypes
Author(s) -
Talma Nynke,
Gerrits Emma,
Wang Boshi,
Eggen Bart J.L.,
Demaria Marco
Publication year - 2021
Publication title -
aging cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.103
H-Index - 140
eISSN - 1474-9726
pISSN - 1474-9718
DOI - 10.1111/acel.13450
Subject(s) - microglia , biology , neurodegeneration , inflammation , trem2 , senescence , central nervous system , microbiology and biotechnology , phagocytosis , immunology , disease , neuroscience , pathology , medicine
Cells expressing high levels of the cyclin‐dependent kinase (CDK)4/6 inhibitor p16 (p16 High ) accumulate in aging tissues and promote multiple age‐related pathologies, including neurodegeneration. Here, we show that the number of p16 High cells is significantly increased in the central nervous system (CNS) of 2‐year‐old mice. Bulk RNAseq indicated that genes expressed by p16 High cells were associated with inflammation and phagocytosis. Single‐cell RNAseq of brain cells indicated p16 High cells were primarily microglia, and their accumulation was confirmed in brains of aged humans. Interestingly, we identified two distinct subpopulations of p16 High microglia in the mouse brain, with one being age‐associated and one present in young animals. Both p16 High clusters significantly differed from previously described disease‐associated microglia and expressed only a partial senescence signature. Taken together, our study provides evidence for the existence of two p16‐expressing microglia populations, one accumulating with age and another already present in youth that could positively and negatively contribute to brain homeostasis, function, and disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom